Month: October 2019

Geographic atrophy Market: Top treatments impacting Geographic atrophy therapeutics market

Business Consultant, DelveInsight's Drug Report, Pharma Consultant, Snippets

Geographic atrophy (GA) is a severe, progressive, irreversible vision loss in old age people. The loss in the vision is due to the damage...

Read More

World Psoriasis Day

Business Consultant, Infographics, Pharma Consultant

World Psoriasis Day, observed on 29th October every year to raise awareness globally and spread information about psoriasis and psoriatic...

Read More

Refractory Metastatic Melanoma Market: A closer look at Melanoma therapies and pipeline products

Articles, Business Consultant, DelveInsight's Oncology based Reports, Pharma Consultant

The cases of Melanoma have been on a hike for the past thirty years making it the fifth most common cancer among people. By the end of the...

Read More

Onychomycosis therapeutics market: Impact of new topical anti-fungal drugs

Articles

A very common, although not a life-threatening fungal infection of the nail, Onychomycosis is regarded as a serious health problem because...

Read More

In a risky affair, Biogen seeks the FDA approval to revive its Alzheimer’s drug Aducanumab

Business Consultant, DelveInsight's Drug Report, Pharma Consultant, Snippets

Not a long time ago this year, Biogen announced the halting of Phase III clinical trials, EMERGE and ENAGE, of its most looked upon drug...

Read More
Close